Alfresa Holdings Corporation (TYO:2784)

Market Cap	391.44B
Revenue (ttm)	2,996.80B
Net Income (ttm)	27.96B
Shares Out	181.90M
EPS (ttm)	151.66
PE Ratio	14.19
Forward PE	12.95
Dividend	68.00 (3.16%)
Ex-Dividend Date	Sep 29, 2025

Volume	262,400
Average Volume	409,005
Open	2,152.50
Previous Close	2,147.50
Day's Range	2,148.50 - 2,160.00
52-Week Range	1,897.00 - 2,328.00
Beta	-0.11
RSI	48.05
Earnings Date	Nov 6, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In 2024, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.